Literature DB >> 11605165

Sickle cell disease: current clinical management.

S K Ballas1.   

Abstract

The phenotypic expression of sickle cell disease (SCD) varies greatly among patients and longitudinally in the same patient. The phenotype influences all aspects of the life of affected individuals including social interactions, intimate relationships, family relations, education, employment, and spirituality. The clinical, manifestations of SCD are protean and fall into three major categories: (1) anemia and its sequelae; (2) pain and related issues; and (3) end-organ failure including infection. This review will emphasize the pathophysiology and management of sickle cell pain, as well as organ failure and its management. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11605165     DOI: 10.1016/s0037-1963(01)90024-1

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  7 in total

Review 1.  Pain management in children with sickle cell disease.

Authors:  Jennifer Stinson; Basem Naser
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Paradigms and politics: shaping health care access for sickle cell patients through the discursive regimes of biomedicine.

Authors:  Carolyn Moxley Rouse
Journal:  Cult Med Psychiatry       Date:  2004-09

3.  Iron overload in sickle cell disease.

Authors:  Radha Raghupathy; Deepa Manwani; Jane A Little
Journal:  Adv Hematol       Date:  2010-05-17

4.  Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.

Authors:  San D Keller; Manshu Yang; Marsha J Treadwell; Ellen M Werner; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2014-08-22       Impact factor: 3.186

5.  Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.

Authors:  San Keller; Manshu Yang; Marsha J Treadwell; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2017-06-02       Impact factor: 3.186

6.  Increased theta band EEG power in sickle cell disease patients.

Authors:  Michelle Case; Sina Shirinpour; Huishi Zhang; Yvonne H Datta; Stephen C Nelson; Karim T Sadak; Kalpna Gupta; Bin He
Journal:  J Pain Res       Date:  2017-12-27       Impact factor: 3.133

7.  How I Treat Acute and Persistent Sickle Cell Pain.

Authors:  Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.